Cargando…
Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
Soft tissue sarcomas (STSs) are rare mesenchymal tumors. With more than 80 histological subtypes of STSs, data regarding novel biomarkers of strong prognostic and therapeutic value are very limited. To date, the most important prognostic factor is the tumor grade, and approximately 50% of patients t...
Autores principales: | Ozaniak, Andrej, Vachtenheim, Jiri, Lischke, Robert, Bartunkova, Jirina, Strizova, Zuzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393686/ https://www.ncbi.nlm.nih.gov/pubmed/34440139 http://dx.doi.org/10.3390/biomedicines9080935 |
Ejemplares similares
-
The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials
por: Snajdauf, Martin, et al.
Publicado: (2021) -
Rare Pseudosarcomatous Lesions Posing Diagnostic Challenges: Histopathologic Examination as a Dominant Tool Preventing Misdiagnosis of Proliferative Fasciitis
por: Ozaniak, Andrej, et al.
Publicado: (2022) -
Tumoral and paratumoral NK cells and CD8(+) T cells of esophageal carcinoma patients express high levels of CD47
por: Strizova, Zuzana, et al.
Publicado: (2020) -
Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report
por: Vachtenheim, Jiri, et al.
Publicado: (2020) -
Diagnostic challenges and treatment options in patients with solitary fibrous tumor: A single-center observational study
por: Ozaniak, Andrej, et al.
Publicado: (2022)